Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Gross Profit | 20,810 | 13,110 | 13,930 | 9,680 | 9,650 |
| Operating Expenses | 13,220 | 10,800 | 6,610 | 4,930 | 6,830 |
| Operating Income | -13,220 | -10,800 | -6,610 | -4,930 | -6,830 |
| Pre-tax Income | -13,220 | -10,800 | -6,610 | -4,930 | -6,830 |
| Net Income Continuous | -13,220 | -10,800 | -6,610 | -4,930 | -6,830 |
| Net Income | $-13,220 | $-10,800 | $-6,610 | $-4,930 | $-6,830 |
| EBITDA(a) | $-12,750 | $-10,300 | $-6,350 | $-4,770 | $-6,690 |